trending Market Intelligence /marketintelligence/en/news-insights/trending/vdddmudoejbf4sfmbo0fta2 content esgSubNav
In This List

ContraFect starts common stock offering

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


ContraFect starts common stock offering

Yonkers, N.Y.-based ContraFect Corp. launched an underwritten public offering for its common stock.

All shares in the offering will be sold by the clinical-stage biotechnology company.

Piper Jaffray & Co. and William Blair & Co. LLC are acting as joint book-running managers for the offering.